Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium bergheiPLOS ONE, 2010
- Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacyMalaria Journal, 2010
- Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’Parasite Immunology, 2009
- Progress and Prospects: The design and production of plasmid vectorsGene Therapy, 2009
- Enhancement of DNA tumor vaccine efficacy by gene gun–mediated codelivery of threshold amounts of plasmid-encoded helper antigenBlood, 2009
- Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodiesMalaria Journal, 2008
- Heterologous Protein Expression Is Enhanced by Harmonizing the Codon Usage Frequencies of the Target Gene with those of the Expression HostPLOS ONE, 2008
- C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium bergheiVaccine, 2007
- Type I Interferons are essential for the efficacy of replicase-based DNA vaccinesVaccine, 2006
- C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malariaInternational Immunology, 2005